Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney" [Matrix Biology 68-69 (2018) 293-317].

Matrix biology : journal of the International Society for Matrix Biology·2026
Same author

Restoring Balance in Autoimmune Hepatitis.

Cellular and molecular gastroenterology and hepatology·2026
Same author

Inhibition of pyrimidine de novo synthesis fosters Treg cells and reduces diabetes development in models of Type 1 Diabetes.

Molecular metabolism·2025
Same author

The XCL1/XCR1 axis is upregulated in type 1 diabetes and aggravates its pathogenesis.

JCI insight·2025
Same author

Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.

EBioMedicine·2024
Same author

Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice.

Journal of autoimmunity·2024

Related Experiment Video

Updated: Jun 13, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Cytochrome P450 2D6 as a model antigen.

Urs Christen1, Martin Holdener, Edith Hintermann

  • 1Klinikum der Goethe-Universität Frankfurt am Main, Pharmazentrum/ZAFES, Frankfurt am Main, Germany. christen@med.uni-frankfurt.de

Digestive Diseases (Basel, Switzerland)
|May 13, 2010
PubMed
Summary

A new mouse model for autoimmune hepatitis (AIH) uses human Cytochrome P450 2D6 (CYP2D6) to induce liver damage. This model reveals molecular mimicry as a key factor in breaking self-tolerance and causing AIH.

More Related Videos

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Experiment Videos

Last Updated: Jun 13, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Area of Science:

  • Immunology
  • Hepatology
  • Autoimmunity

Background:

  • Autoimmune hepatitis (AIH) etiology is unclear due to limited animal models.
  • Cytochrome P450 2D6 (CYP2D6) is a key autoantigen in type 2 AIH.
  • Understanding AIH pathogenesis requires a suitable experimental model.

Purpose of the Study:

  • To develop and characterize a novel mouse model for AIH using human CYP2D6.
  • To investigate the role of molecular mimicry in breaking self-tolerance in AIH.
  • To explore the immunopathogenesis of autoimmune liver injury.

Main Methods:

  • Adenovirus-mediated expression of human CYP2D6 (Ad-2D6) in wild-type and transgenic mice.
  • Assessment of liver damage, including fibrosis, necrosis, and inflammation.
  • Quantification of anti-CYP2D6 antibodies and analysis of CYP2D6-specific T cell responses.
  • Evaluation of immune tolerance mechanisms through peptide homology studies.

Main Results:

  • Ad-2D6 infection induced persistent liver damage, fibrosis, and anti-CYP2D6 antibodies in wild-type mice.
  • Transgenic mice expressing human CYP2D6 showed reduced liver damage severity and delayed kinetics.
  • T cell tolerance was significantly stronger in human CYP2D6 transgenic mice.
  • Molecular mimicry between human CYP2D6 and mouse homologues, rather than identity, was identified as the trigger for tolerance breakdown.

Conclusions:

  • The developed CYP2D6 mouse model effectively recapitulates key features of human AIH.
  • Molecular mimicry is a critical mechanism in initiating autoimmune liver disease.
  • This model serves as a valuable platform for studying AIH mechanisms and therapeutic strategies.